CPhI Worldwide, ICSE, P-MEC
and BioPh 2009 Preview
As CPhI Worldwide returns to popular Madrid, its directors outline what attendees
have to look forward to at one of pharma's biggest events
CPhI Worldwide – with ICSE, P-MEC and and themes explained by opinion leaders Speakers’ Corner,
a new offering, BioPh – makes its second in the active pharmaceutical ingredients taking place at CPhI
visit to Spain's popular Feria de Madrid (API), contract manufacturing organisation and ICSE. The Madrid
from October 13th-15th, 2009. This year (CMO), clinical trials and biomanufacturing events will refl ect the
also marks the 20th anniversary of the segments. evolution of CPhI into a
world’s largest dedicated pharmaceutical “24/7/365” information brand, via
Following on from their successful debut
ingredients, services and equipment digital platforms accessed through
last year, the Breakfast Briefi ngs will return
exhibition and networking event. wherepharmameets.com.
on the fi rst two mornings of the event.
Much has changed since our Madrid Focused on critical industry issues, these Whatever your plans for Madrid, we
debut in 2005. Companies' business briefi ngs are to be run in conjunction with hope our events will meet and exceed
models in the pharmaceutical ingredients, the CPhI Conferences group and, once your needs and expectations!
production and services areas have again, in partnership with the European Fine
Annemieke Timmers
all needed to adapt to the challenges Chemicals Group (EFCG).
Event director, CPhI
witnessed right across the healthcare
Other highlight features include the sixth Haf Cennydd
innovation and production spectrum.
annual CPhI Innovation Awards and the Event director, ICSE, P-MEC & BioPh
As the markets evolve, CPhI and its
associated events have become ever more
important marketing and networking
3
platforms.
Four years ago, attendance in Madrid
topped 21,000. Our Frankfurt events
last autumn drew in more than 25,000
attendees, underlining recognition of
CPhI, ICSE and P-MEC as one of industry’s
premier annual meeting places.
Audiences are evolving in line with market
changes. To refl ect the accelerating
convergence and deepening relationships
between the pharmaceutical and
*O
4BGF
)BOET
)JHIMZ
1PUFOU
"1*T
biotechnology sectors in delivering global
healthcare and production services,
Lonza Custom Manufacturing – with more than a R&D Capabilities
Madrid will host the formal launch of the decade of experience and over 10 highly potent – dedicated small molecule,
all-new BioPh: Bio-solutions for Pharma
products taken from early development to com- peptide and conjugate laboratories
mercialization, Lonza has the technical know-how, – associated QA / QC laboratories
event.
cutting-edge facilities, and reliable evaluation and – over 10 products scaled up (early clinical to launch)
training procedures you can trust.
New features introduced at CPhI, ICSE, Antibody Drug Conjugate Facilities
2
P-MEC and BioPh 2009 will include the
High Potent Facilities
1
(Visp, Switzerland)
(Visp, Switzerland) multiple 10L – 50L
|
1 x 500L
pre-show seminar series ‘Global Sourcing
4 x 10m
3

|
1 x 2.5m
3

|
1 x 630L
and Contracting Strategies’, taking 1
8 hour occupational exposure limit down to 0.1 µg/m
3
2
8 hour occupational exposure limit down to 0.04 µg/m
3
place on the afternoon of October
12th. The multi-track format will offer
Tel. +41 61 316 81 11
|
contact@lonza.com
|
We can help: www.Lonza.com
a fully-bookable choice of 30-minute
seminars, offering insights into key trends
2009_04_Scrip.indd 1 23.04.2009 16:46:24
Scrip World Pharmaceutical News Supplement August 2009
cphi.com | icsexpo.com | p-mec.com | bioph-online.com
wherepharmameets.com | scripnews.com
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44